Concepedia

Publication | Open Access

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

DOIFull Paper Access

102

Citations

7

References

2013

Year

Calogero Cammà, Giuseppe Cabibbo, Salvatore Petta, Marco Enea, Massimo Iavarone, Antonio Grieco, Antonio Gasbarrini, Erica Villa, Claudio Zavaglia, Raffaele Bruno,
Hepatology

Abstract

In daily practice dose-adjusted, but not full-dose, sorafenib is a cost-effective treatment compared to BSC in intermediate and advanced HCC.

References

YearCitations

Page 1